{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T01:08:34Z","timestamp":1779066514217,"version":"3.51.4"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"DOI":"10.1038\/s44321-026-00380-1","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T16:02:54Z","timestamp":1771257774000},"page":"855-857","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A renewed perspective on TCA intermediate cis-aconitate: mechanisms and therapeutic options against influenza virus"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4962-6568","authenticated-orcid":false,"given":"Claudia","family":"Claus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Kovacevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"380_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00018-025-05611-1","volume":"82","author":"A Bonomini","year":"2025","unstructured":"Bonomini A, Mercorelli B, Loregian A (2025) Antiviral strategies against influenza virus: an update on approved and innovative therapeutic approaches. Cell Mol Life Sci 82:75","journal-title":"Cell Mol Life Sci"},{"key":"380_CR2","doi-asserted-by":"publisher","unstructured":"Cezard A, Brea-Diakite D, Vasseur V, Wacquiez A, Gonzalez L, Le Goffic R, Da Costa B, Tinard A, Fouquenet P, Heumel S et al (2026) Cis-aconitate therapy protects against influenza mortality by dual targeting of viral polymerase 1 and ERK\/AKT\/NF-\u03baB signaling. EMBO Mol Med. https:\/\/doi.org\/10.1038\/s44321-026-00379-8","DOI":"10.1038\/s44321-026-00379-8"},{"key":"380_CR3","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s00011-025-02087-4","volume":"74","author":"H Gao","year":"2025","unstructured":"Gao H, Ding M, Liu Y, Wang Y, Zhao S, Chen J, Chen Z, Wang G (2025) Reprogramming immunity with itaconate: metabolic mechanisms and therapeutic perspectives. Inflamm Res 74:128","journal-title":"Inflamm Res"},{"key":"380_CR4","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021108306","volume":"41","author":"A Guillon","year":"2022","unstructured":"Guillon A, Brea-Diakite D, Cezard A, Wacquiez A, Baranek T, Bourgeais J, Picou F, Vasseur V, Meyer L, Chevalier C et al (2022) Host succinate inhibits influenza virus infection through succinylation and nuclear retention of the viral nucleoprotein. EMBO J 41:e108306","journal-title":"EMBO J"},{"key":"380_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.725043","volume":"11","author":"FJ Sanchez-Garcia","year":"2021","unstructured":"Sanchez-Garcia FJ, Perez-Hernandez CA, Rodriguez-Murillo M, Moreno-Altamirano MMB (2021) The role of tricarboxylic acid cycle metabolites in viral infections. Front Cell Infect Microbiol 11:725043","journal-title":"Front Cell Infect Microbiol"},{"key":"380_CR6","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2025.2471022","volume":"14","author":"A Schreiber","year":"2025","unstructured":"Schreiber A, Oberberg N, Ambrosy B, Rodner F, Kumar S, Caliskan DM, Brunotte L, Beer M, Ludwig S (2025) Influenza H5Nx viruses are susceptible to MEK1\/2 inhibition by zapnometinib. Emerg Microbes Infect 14:2471022","journal-title":"Emerg Microbes Infect"},{"key":"380_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1637436","volume":"16","author":"M Tada","year":"2025","unstructured":"Tada M, Kono M (2025) Metabolites as regulators of autoimmune diseases. Front Immunol 16:1637436","journal-title":"Front Immunol"},{"key":"380_CR8","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/s41423-020-0489-5","volume":"17","author":"R Wu","year":"2020","unstructured":"Wu R, Chen F, Wang N, Tang D, Kang R (2020) ACOD1 in immunometabolism and disease. Cell Mol Immunol 17:822\u2013833","journal-title":"Cell Mol Immunol"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00380-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-026-00380-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00380-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:44:21Z","timestamp":1779065061000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-026-00380-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":8,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,13]]}},"alternative-id":["380"],"URL":"https:\/\/doi.org\/10.1038\/s44321-026-00380-1","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"15 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}